Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells. 2005

Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
Laboratory for Molecular Stem Cell Biology, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Pre-B cells undergo apoptosis unless they are rescued by pre-B cell receptor-dependent survival signals. We previously showed that the BCR-ABL1 kinase that is expressed in pre-B lymphoblastic leukemia bypasses selection for pre-B cell receptor-dependent survival signals. Investigating possible interference of BCR-ABL1 with pre-B cell receptor signaling, we found that neither SYK nor SLP65 can be phosphorylated in response to pre-B cell receptor engagement. Instead, Bruton's tyrosine kinase (BTK) is constitutively phosphorylated by BCR-ABL1. Activated BTK is essential for survival signals that otherwise would arise from the pre-B cell receptor, including activation of PLCgamma1, autonomous Ca2+ signaling, STAT5-phosphorylation, and up-regulation of BCLX(L). Inhibition of BTK activity specifically induces apoptosis in BCR-ABL1+ leukemia cells to a similar extent as inhibition of BCR-ABL1 kinase activity itself. However, BCR-ABL1 cannot directly bind to full-length BTK. Instead, BCR-ABL1 induces the expression of a truncated splice variant of BTK that acts as a linker between the two kinases. As opposed to full-length BTK, truncated BTK lacks kinase activity yet can bind to BCR-ABL1 through its SRC-homology domain 3. Acting as a linker, truncated BTK enables BCR-ABL1-dependent activation of full-length BTK, which initiates downstream survival signals and mimics a constitutively active pre-B cell receptor.

UI MeSH Term Description Entries
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
December 2009, Cell cycle (Georgetown, Tex.),
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
January 2011, Expert review of anticancer therapy,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
January 1990, Leukemia & lymphoma,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
July 1979, Blood,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
December 2023, PLoS genetics,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
November 2015, JAAD case reports,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
August 1999, American journal of hematology,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
November 1984, Blood,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
August 2013, Blood,
Niklas Feldhahn, and Florian Klein, and Jana L Mooster, and Paul Hadweh, and Mieke Sprangers, and Maria Wartenberg, and Mohamed M Bekhite, and Wolf-Karsten Hofmann, and Sebastian Herzog, and Hassan Jumaa, and Janet D Rowley, and Markus Müschen
August 2015, The American Journal of dermatopathology,
Copied contents to your clipboard!